机构：[1]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China临床科室耳鼻咽喉-头颈外科首都医科大学附属北京同仁医院首都医科大学附属同仁医院[2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China研究所耳鼻咽喉科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[3]Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China临床科室变态反应科首都医科大学附属北京同仁医院首都医科大学附属同仁医院
The prevalence of allergic rhinitis (AR) has witnessed a progressive increase in China. A survey of self-reported AR using validated questionnaire-based telephone interviews in adult subjects conducted between 2004 and 2005 demonstrated that the prevalence of AR in 11 major cities across China was 11.1%1 . A subsequent survey of self-reported AR in adult residents of 18 major cities in China, conducted from 2005 to 2011, has reported that the prevalence of AR in 2011 had increased markedly to 17.6%2 . In particular, of the 11 cities in the original survey, which were also included in the second survey, the prevalence of AR had significantly increased in eight.This article is protected by copyright. All rights reserved.
基金：
This work was supported by grants from National Key R & D Program
of China (2016YFC20160905200) and the Program for Changjiang
Scholars and Innovative Research Team (IRT13082).
第一作者机构：[1]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China[2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China
通讯作者：
通讯机构：[1]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China[2]Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China[3]Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China[*1]Beijing Institute of Otolaryngology, No. 17, HouGouHuTong, DongCheng District, Beijing 100005, China.
推荐引用方式(GB/T 7714)：
Xian Mu,Zhang Luo.Artemisia annua-sublingual immunotherapy: First step to cross the chasm[J].ALLERGY.2021,76(2):425-427.doi:10.1111/all.14539.
APA：
Xian, Mu&Zhang, Luo.(2021).Artemisia annua-sublingual immunotherapy: First step to cross the chasm.ALLERGY,76,(2)
MLA：
Xian, Mu,et al."Artemisia annua-sublingual immunotherapy: First step to cross the chasm".ALLERGY 76..2(2021):425-427
医学